@admin / longevity-researchmission

Longevity Research

Succeeded
Elapsed
449.7s
Cost
Free
Tokens
0
0 in · 0 out
Events
28
click to inspect
live output
Starting mission longevity-research…
==> Longevity-research mission tick starting
==> Swarm tick starting. KB: {'entities': 131, 'relations': 0}
── Phase 1: Director
==> Goal: Anchor the first human-validated causal relation in the mTORC1–autophagy–inflammaging axis by re-gating to the IL-6/hs-C
Focus: FOCUS AREAS:
1. **Colocalized Mendelian Randomization of RPTOR and TSC2 cis-pQTLs on the IL-6/hs-CRP dyad**: Use high-powered cis-pQTL instruments for RPTOR and TSC2 (deCODE/UKB-PPP) to perform bidir
── Phase 2: Scouts
[clinicaltrials] fetched 0 items
[opentargets] error: HTTP Error 400: Bad Request
[opentargets] fetched 0 items
[medrxiv] fetched 30 items
[biorxiv] fetched 30 items
[pubmed] esearch error: <urlopen error [Errno -3] Temporary failure in name resolution>
[pubmed] fetched 0 items
[europepmc] fetched 60 items
Items: 120
── Phase 3: Synthesizer
── Phase 4: Critic
── Phase 5: Curator
── Phase 6: Reporter
Findings: 0, Hypotheses: 3
── Phase 7: Director-meta
==> Tick complete. Findings: 0, Hypotheses: 3
==> Tick complete.
Outputs
{
  "result": " This tick, the swarm zeroed in on a single, high-stakes causal question in geroscience: does human genetic variation in the mTORC1 nutrient-sensing pathway drive systemic inflammaging through autophagy? Specifically, we launched a three-pronged investigation targeting the axis from RPTOR/TSC2 protein levels through autophagy mediators (SQSTM1/p62, ATG7, GABARAPL2) to circulating IL-6 and high-sensitivity CRP, with parallel validation in primary human macrophages examining TFEB/TFE3–NF-κB coupling. We must report candidly that this tick yielded **zero new empirical findings** and established **zero causal relations** in the knowledge graph. Instead, the period was foundational: three hypotheses were refined, methodological instruments were selected, and the analytical framework was locked to ensure that when evidence does appear, it will be durable.\n\nWith no discoveries to report yet, the most interesting development this tick is the **investigational design itself**—a deliberately narrow, human-centric strategy intended to anchor causality without relying on non-human models. The biological mechanism under scrutiny posits that mTORC1, a master regulator of cell growth and recycling, normally suppresses autophagy. When mTORC1 activity is genetically or pharmacologically reduced, transcription factors TFEB and TFE3 translocate to the nucleus, activating autophagy genes and simultaneously dampening NF-κB-driven inflammation in macrophages. If this holds in humans, genetically lower mTORC1 signaling (or higher autophagy flux) should causally reduce IL-6 secretion and systemic CRP. The swarm plans to test this using high-powered *cis*-pQTL instruments from deCODE and UKB-PPP as unconfounded genetic proxies, followed by Bayesian colocalization and pleiotropy-robust sensitivity analyses to distinguish shared causal variants from linkage disequilibrium artifacts.\n\n**Evidence strength remains theoretical at this stage.** Our knowledge base now holds 131 entities, but no relations connect them. No human genetic associations, in vitro imaging data, or animal results were produced this tick. However, the planned evidence hierarchy is intentionally rigorous: population-scale Mendelian randomization in humans will be paired with imaging flow cytometry and CRISPRi knockdown in primary human monocyte-derived macrophages. If successful, this combination would provide both population-level causal inference and cell-autonomous mechanistic resolution—bypassing the translational ambiguity that often plagues invertebrate or rodent aging studies. The trade-off is a higher detection threshold; by excluding trans-pQTLs and low-F-statistic instruments, we sacrifice breadth for confidence.\n\n**Outstanding questions dominate the next tick’s agenda.** Can we detect colocalized causal variants shared between RPTOR/TSC2 protein abundance and IL-6 or hs-CRP? If a genetic signal exists, does it operate through autophagy flux—as tested by multivariable mediation MR via SQSTM1/p62 and ATG7—or through an independent pathway? And in human macrophages, will mTORC1 inhibition (rapamycin/Torin1) or TFEB/TFE3 knockdown produce quantifiable shifts in nuclear p65/RelA and measurable IL-6 secretion? The swarm will execute the MR/coloc pipelines and process the macrophage validation experiments next, maintaining strict deprioritization of broader cytokine panels and non-human models until this first causal edge is either anchored or falsified.\n\n**Overall confidence in the biological direction is moderate and speculative, though methodologically guarded.** The mTOR-autophagy-inflammation nexus is well-precedented in preclinical literature, yet human genetic evidence for causal directionality remains sparse and potentially confounded by pleiotropy. Our confidence lies not in the result—we have none yet—but in the rigor of the approach: bidirectional MR, colocalization, and pleiotropy-robust sensitivity checks should ensure that any future positive finding reflects a genuine causal relationship rather than a spurious correlation. We expect the next tick to either populate the first relations on this axis or sharply constrain the hypothesis space.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 3
}
Inference calls7